awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36673751-195EE140-F0FA-445A-BABE-6361CC8CC574
Q36673751-195EE140-F0FA-445A-BABE-6361CC8CC574
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-195EE140-F0FA-445A-BABE-6361CC8CC574
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
P2860
Q36673751-195EE140-F0FA-445A-BABE-6361CC8CC574
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-195EE140-F0FA-445A-BABE-6361CC8CC574
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80ea7c2cf7e7344ab33e97426c8f36d9e11982d8
P2860
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial